Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2285235rdf:typepubmed:Citationlld:pubmed
pubmed-article:2285235lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0065175lld:lifeskim
pubmed-article:2285235lifeskim:mentionsumls-concept:C0073177lld:lifeskim
pubmed-article:2285235pubmed:issue6lld:pubmed
pubmed-article:2285235pubmed:dateCreated1991-3-15lld:pubmed
pubmed-article:2285235pubmed:abstractTextThe effect of Rhein (RH) and Lonidamine (LND) on the clonogenic activity of cultured human glioma cells has been evaluated. Both these drugs decrease the survival fraction, but their effect is strictly related to the duration of exposure. A brief exposure, i.e. 4 hours, even at the highest drug concentrations does not induce any significant decrease in the survival which, on the contrary, is strongly affected by 24 and 48 hours of exposure. The reason for this behaviour lies in the mechanism of action of these drugs which do not interfere with replicative processes, but selectively affect the energy metabolism of the neoplastic cell. The validity of currently employed screening tests to evaluate the antitumoral activity of non anti-mitotic drugs is also discussed.lld:pubmed
pubmed-article:2285235pubmed:languageenglld:pubmed
pubmed-article:2285235pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:citationSubsetIMlld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2285235pubmed:statusMEDLINElld:pubmed
pubmed-article:2285235pubmed:issn0250-7005lld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:FloridiAAlld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:BenassiMMlld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:BruniRRlld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:GentileF PFPlld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:CastiglioneSSlld:pubmed
pubmed-article:2285235pubmed:authorpubmed-author:ZeuliMMlld:pubmed
pubmed-article:2285235pubmed:issnTypePrintlld:pubmed
pubmed-article:2285235pubmed:volume10lld:pubmed
pubmed-article:2285235pubmed:ownerNLMlld:pubmed
pubmed-article:2285235pubmed:authorsCompleteYlld:pubmed
pubmed-article:2285235pubmed:pagination1633-6lld:pubmed
pubmed-article:2285235pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:meshHeadingpubmed-meshheading:2285235-...lld:pubmed
pubmed-article:2285235pubmed:articleTitleGrowth inhibition by rhein and lonidamine of human glioma cells in vitro.lld:pubmed
pubmed-article:2285235pubmed:affiliationLaboratory for Cell Metabolism and Pharmacokinetics, Regina Elena Institute for Cancer Research, Rome, Italy.lld:pubmed
pubmed-article:2285235pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2285235pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed